Source link : https://www.newshealth.biz/health-news/car-t-warning-for-secondary-malignancies-warranted-or-not/
Early in 2024, we reported on the FDA’s call for new boxed warnings on the labeling of all approved chimeric antigen receptor (CAR) T-cell therapies for the potential risk for secondary T-cell malignancies. In this report, we follow up on what has happened since. In January 2024, the FDA mandated new boxed warnings on approved […]
Author : News Health
Publish date : 2025-01-05 14:00:00
Copyright for syndicated content belongs to the linked Source.
inHealth